par Rozenberg, Serge 
;Vandromme, Jean ;Kroll, Marie ;Twagirayezu, Pierre;Vyankandondera, Joseph
Référence Revue médicale de Bruxelles, 16, 4, page (295-298)
Publication Publié, 1995
;Vandromme, Jean ;Kroll, Marie ;Twagirayezu, Pierre;Vyankandondera, JosephRéférence Revue médicale de Bruxelles, 16, 4, page (295-298)
Publication Publié, 1995
Article révisé par les pairs
| Résumé : | Hormone Replacement Therapy (HRT) after menopause reduces climacteric symptoms and increases the quality of life. If correct dosage is used, bone loss can be prevented and fracture frequency reduced. Epidemiological studies also suggest a decreased cardio-vascular mortality among HRT users. A high proportion of post-menopausal women should therefore be treated using long-term therapy, but currently only a small proportion of women use HRT in Belgium, (around 14%). Further their compliance is particularly low. Fear of cancer and drug-related side effects, such as unaccepted bleeding are often mentioned causes of low compliance. Education of both physicians and patients, regarding HRT seems to be a crucial issue. The physician's attitude towards HRT is often reported as negative. Osteoporosis prevention and related bone mass measurements may have a favorable effect on compliance, but this is not well established. Establishing a confidential relationship with patients and the involvement of nursing counseling are strategies which may improve compliance. The use of easy-to-take medications supported by calendar blisters or reminders, may facilitate chronic use of medication. Future research needs to investigate the physician's and the patient's decision-making process. |
